bicalutamide has been researched along with Gynecomastia in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 22 (68.75) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Chernomordikov, E; Lavrenkov, K; Mermershtain, W; Rouvinov, K | 1 |
| Aebersold, DM; Albrecht, C; Böhmer, D; Flentje, M; Ganswindt, U; Ghadjar, P; Höcht, S; Hölscher, T; Müller, AC; Niehoff, P; Pinkawa, M; Sedlmayer, F; Wiegel, T; Zips, D | 1 |
| Baumgarten, L; Dabaja, AA | 1 |
| Bahary, JP; Balogh, AG; Dignam, JJ; Feng, FY; Grignon, DJ; Heney, NM; Kerlin, KJ; Lawton, CA; Lovett, RD; Lukka, HR; Major, PP; Patel, MP; Pisansky, TM; Pugh, SL; Rosenthal, SA; Sandler, HM; Sartor, O; Seiferheld, W; Shipley, WU; Souhami, L; Zeitzer, KL; Zietman, AL | 1 |
| Argusti, A; Bandelloni, R; Branchi, D; Campodonico, F; Decensi, A; Maffezzini, M; Montironi, R; Mori, M; Puntoni, M; Turbino, L; Zanardi, S | 1 |
| Aragona, F; Bedognetti, D; Boccardo, F; Canclini, L; Conti, G; Cortellini, P; De Cobelli, O; Di Tonno, P; Francesca, F; Gallucci, M; Lapini, A; Martorana, G; Rubagotti, A | 1 |
| Abay, E; Akpinar, H; Akyol, F; Cureklibatur, I; Eskicorapci, S; Karaman, I; Kuyumcuoglu, U; Ozen, H; Sengor, F; Sengoz, M; Toktas, G; Unluer, E; Yalcin, V; Zorlu, F | 1 |
| Allegro, R; Altieri, V; De Grande, G; Ferraù, F; Gebbia, V; Mazza, R; Melloni, D; Morgia, G; Nicolosi, F; Serretta, V | 1 |
| Chowdhury, S; Davda, R; Khan, A; Payne, H | 1 |
| Keshtgar, MR; Michalopoulos, NV | 1 |
| Mcleod, DG | 1 |
| Andersson, SO; Bakke, A; Boon, T; Carroll, K; Goedhals, L; Lodding, P; Morris, T; Payne, H; Tammela, TL; Tyrrell, CJ; Van De Beek, C; Van Erps, P | 1 |
| Battaglia, M; Bertaccini, A; Boccardo, F; Comeri, G; Conti, G; Di Tonno, P; Durand, F; Ferraris, V; Galassi, P; Macchiarella, A; Manganelli, A; Martorana, G; Montefiore, F; Muscas, G; Potenzoni, D; Rubagotti, A; Selvaggi, FP; Siragusa, A; Zattoni, F | 1 |
| Gallo, J; Morris, T; Saltzstein, D; Sieber, P | 1 |
| Chianakwalam, CI; Griffiths, NJ; McCahy, P | 1 |
| Cangh, PV; Colombeau, P; Garside, L; Haustermans, K; Keuppens, F; Morris, T; Tyrrell, CJ; Van Poppel, H | 1 |
| Boccardo, F; Conti, G; Del Monaco, D; Manganelli, A; Potenzoni, D; Rubagotti, A | 1 |
| Autorino, R; Bianco, AR; D'Armiento, M; Damiano, R; De Placido, S; De Sio, M; Di Lorenzo, G; Gallo, A; Gallo, L; Perdonà, S; Pingitore, D | 1 |
| Thönnessen, D; Wenz, F | 1 |
| Autorino, R; D'Armiento, M; Damiano, R; De Placido, S; De Sio, M; Di Lorenzo, G; Gallo, A; Gallo, L; Perdonà, S; Pingitore, D | 1 |
| Bartlett, RA; Nakabayashi, M; Oh, WK | 1 |
| Autorino, R; Di Lorenzo, G | 1 |
| Andersen, M; Armstrong, J; Egerdie, B; Fradet, Y; Morris, T; Nachabe, M; Navani, S; Tammela, TL | 1 |
| Van Poppel, H | 1 |
| Dawkins, GP; Harris, JP; Nuttall, MC | 1 |
| Abdah-Bortnyak, R; Bernstein, Z; Kuten, A; Ramon, N; Shnaider, J; Zalman, D | 1 |
| Haddad, E | 1 |
| Dewilde, S; Kleinman, L; Lloyd, A; Penson, D | 1 |
| Sieber, PR | 1 |
| Bloemena, E; Hage, JJ; Kanhai, RC; Mulder, JW; van Diest, PJ | 1 |
| Borchers, TM; Delaere, KP; Hetherington, J; Heynes, CF; Morris, T; Pina, F; Ramon, J; Sánchez-Chapado, M; Stone, A; Tyrrell, C; Wallace, M; Wirth, M | 1 |
| Denis, L; Mahler, C | 1 |
7 review(s) available for bicalutamide and Gynecomastia
| Article | Year |
|---|---|
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Topics: Adenocarcinoma; Anastrozole; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Dizziness; Dose Fractionation, Radiation; Drug Administration Schedule; Estrogen Receptor Modulators; Flushing; Gynecomastia; Humans; Male; Mastodynia; Meta-Analysis as Topic; Neoplasms, Hormone-Dependent; Nitriles; Off-Label Use; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tamoxifen; Tosyl Compounds | 2020 |
Diagnosis and Management of Gynecomastia for Urologists.
Topics: Androgen Antagonists; Anilides; Estrogen Antagonists; Gynecomastia; Humans; Male; Nitriles; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds | 2018 |
Hormone therapy for radiorecurrent prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Gynecomastia; Humans; Male; Mastodynia; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy; Recurrence; Risk Factors; Tosyl Compounds; Treatment Failure; Treatment Outcome | 2013 |
Emerging role of adjuvant hormonal therapy.
Topics: Androgen Antagonists; Anilides; Chemotherapy, Adjuvant; Gynecomastia; Humans; Male; Neoplasm Staging; Nitriles; Pain; Prostatectomy; Prostatic Neoplasms; Quality of Life; Radiotherapy, Adjuvant; Tosyl Compounds | 2002 |
[Gynecomastia as a complication of hormonotherapy for prostate cancer: effect of prophylactic breast irradiation].
Topics: Androgen Antagonists; Anilides; Breast; Gynecomastia; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2007 |
[Management of gynecomastia induced by bicalutamide].
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Gynecomastia; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2006 |
Treatment of bicalutamide-induced breast events.
Topics: Androgen Antagonists; Anilides; Clinical Trials as Topic; Estrogen Receptor Modulators; Gynecomastia; Humans; Male; Nitriles; Pain; Pain Management; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds | 2007 |
14 trial(s) available for bicalutamide and Gynecomastia
| Article | Year |
|---|---|
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Gynecomastia; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Rate; Tosyl Compounds | 2017 |
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Biopsy; Dose-Response Relationship, Drug; Gynecomastia; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds | 2009 |
An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.
Topics: Aged; Anilides; Antineoplastic Agents; Drug Administration Schedule; Estrogen Antagonists; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds | 2010 |
Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?
Topics: Aged; Anilides; Antineoplastic Agents; Breast Neoplasms, Male; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds | 2010 |
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia.
Topics: Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Chemotherapy, Adjuvant; Estrogen Antagonists; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Statistics, Nonparametric; Tamoxifen; Tosyl Compounds; Treatment Outcome | 2012 |
Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Breast; Breast Diseases; Confidence Intervals; Double-Blind Method; Electrons; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prostatic Neoplasms; Tosyl Compounds | 2004 |
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.
Topics: Aged; Aged, 80 and over; Anastrozole; Anilides; Breast Diseases; Double-Blind Method; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Tamoxifen; Testosterone; Tosyl Compounds; Triazoles | 2005 |
Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole.
Topics: Aged; Aged, 80 and over; Anastrozole; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Diseases; Double-Blind Method; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Placebos; Prostatic Neoplasms; Tamoxifen; Testosterone; Tosyl Compounds; Treatment Outcome; Triazoles | 2005 |
Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.
Topics: Adenocarcinoma; Age of Onset; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Breast; Follow-Up Studies; Gynecomastia; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Nitriles; Pain; Prostatic Neoplasms; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2005 |
Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
Topics: Aged; Aged, 80 and over; Anastrozole; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Interactions; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds; Triazoles | 2005 |
Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Combined Modality Therapy; Disease-Free Survival; Estrogen Antagonists; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds | 2005 |
Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Topics: Aged; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Chemotherapy, Adjuvant; Disease-Free Survival; Estrogen Receptor Modulators; Follow-Up Studies; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Penile Erection; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Radiotherapy, Adjuvant; Severity of Illness Index; Tamoxifen; Testosterone; Time Factors; Tosyl Compounds; Treatment Outcome | 2005 |
Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Antagonists; Follow-Up Studies; Gynecomastia; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Nitriles; Pain; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds; Treatment Outcome | 2007 |
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Biomarkers, Tumor; Confidence Intervals; Disease Progression; Disease-Free Survival; Double-Blind Method; Follow-Up Studies; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Pain; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Tosyl Compounds | 2001 |
11 other study(ies) available for bicalutamide and Gynecomastia
| Article | Year |
|---|---|
Prophylactic Breast Irradiation for Prevention of Bicalutamide-induced Painful Gynecomastia in Patients with Low- and Intermediate-risk Prostate Cancer.
Topics: Androgen Antagonists; Gynecomastia; Humans; Male; Pain; Prospective Studies; Prostatic Neoplasms | 2023 |
Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment.
Topics: Androgen Antagonists; Anilides; Chemotherapy, Adjuvant; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2012 |
A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Breast Neoplasms, Male; Gynecomastia; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Radiotherapeutic prophylaxis of gynecomastia.
Topics: Anastrozole; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Gynecomastia; Humans; Male; Nitriles; Pain; Prostatic Neoplasms; Quality of Life; Tamoxifen; Tosyl Compounds; Triazoles | 2005 |
Treatment of bicalutamide-induced gynecomastia with breast-reduction surgery in prostate cancer.
Topics: Anilides; Antineoplastic Agents, Hormonal; Gynecomastia; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2006 |
Bicalutamide-induced gynaecomastia: do we have the answer?
Topics: Anilides; Antineoplastic Agents; Follow-Up Studies; Gynecomastia; Humans; Incidence; Male; Neoplasm Staging; Nitriles; Prostatic Neoplasms; Risk Factors; Time Factors; Tosyl Compounds | 2007 |
Editorial comment on: Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.
Topics: Androgen Antagonists; Anilides; Dose-Response Relationship, Drug; Estrogen Antagonists; Follow-Up Studies; Gynecomastia; Humans; Male; Nitriles; Pain; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds; Treatment Outcome | 2007 |
The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Gynecomastia; Humans; Male; Nitriles; Pain; Prostatic Neoplasms; Tamoxifen; Tosyl Compounds; Treatment Outcome | 2007 |
Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Choice Behavior; Cross-Sectional Studies; Diarrhea; Drug Administration Schedule; Drug Costs; Drug Therapy; Erectile Dysfunction; Flutamide; Gynecomastia; Health Surveys; Hematuria; Humans; Life Expectancy; Male; Middle Aged; Nitriles; Patient Acceptance of Health Care; Patient Satisfaction; Prostatic Neoplasms; Tosyl Compounds | 2008 |
Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Breast; Castration; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Gynecomastia; Humans; Male; Mastectomy, Subcutaneous; Metaplasia; Nitriles; Orchiectomy; Time Factors; Tosyl Compounds; Transsexualism | 2000 |
Clinical profile of a new non-steroidal antiandrogen.
Topics: Androgen Antagonists; Anilides; Follicle Stimulating Hormone; Gynecomastia; Humans; Libido; Luteinizing Hormone; Male; Nitriles; Penile Erection; Prostatic Neoplasms; Tosyl Compounds | 1990 |